Boston Scientific (BSX) Fell Amid Rising Competition
Baron Funds, an investment management company, released its “Baron Health Care Fund” third-quarter 2025 investor letter. A copy of the letter can be downloaded here.
Boston Scientific Corp (BSX)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period: Filing is Ongoing
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Impax Asset Management Ian Simm | 1,727,380 | $168,644,109 | +20% | 0.98% |
| 2. | Diamond Hill Capital Ric Dillon | 278,071 | $27,148,072 | -17% | 0.13% |
| 3. | Bailard Inc Thomas Bailard | 203,447 | $19,862,531 | -2% | 0.43% |
| 4. | ZWEIG DIMENNA PARTNERS Joe Dimenna | 154,450 | $15,078,954 | -1% | 1.06% |
| 5. | Navellier & Associates Louis Navellier | 42,779 | $4,176,514 | -11% | 0.42% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $90.29 | 50 | $4,514.60 | 148,168 | 2024-12-03 | Filing | |
| $41.98 | 25,000 | $1,049,450.00 | 25,000 | 2021-11-15 | Filing | |
| $27.50 | 13 | $357.50 | 32,337 | 2017-09-01 | Filing | |
| $27.80 | 30 | $834.00 | 32,324 | 2017-06-16 | Filing | |
| $25.52 | 29 | $740.08 | 32,294 | 2017-04-24 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $98.28 | 12,891 | $1,266,977.75 | 24,134 | 2025-11-06 | Filing | |
| $99.14 | 29,472 | $2,921,895.34 | 178,342 | 2025-11-03 | Filing | |
| $99.76 | 16,928 | $1,688,749.13 | 207,814 | 2025-11-03 | Filing | |
| $100.75 | 3,600 | $362,693.16 | 224,742 | 2025-11-03 | Filing | |
| $102.24 | 2,901 | $296,598.82 | 24,134 | 2025-10-28 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 138,249,447 | $13,497,293,511 | 0.2% | |
| 2. | 28,329,209 | $2,765,812,643 | 0.17% | |
| 3. | 11,032,972 | $1,077,149,027 | 0.19% | |
| 4. | 10,367,293 | $1,012,158,815 | 0.31% | |
| 5. | 8,842,313 | $863,275,018 | 0.14% |
News See All
Is Boston Scientific (BSX) Becoming the Leading MedTech Growth Story?
Boston Scientific Corp. (NYSE:BSX) is one of the best stocks to buy according to Citadel LLC.
13 Best Stocks to Buy According to Citadel LLC
Citadel LLC (formerly known as Citadel Investment Group) is known as one of the most successful and profitable alternative asset managers.
10 Best Stocks to Buy for High Returns Heading into 2026
On October 27, Nicolas Janvier, Head of North America Equities at Columbia Threadneedle Investments, joined CNBC television for an interview.
Boston Scientific Corporation (NYSE:BSX) Q3 2025 Earnings Call Transcript
Operator: Good morning, and welcome to the Boston Scientific Third Quarter 2025 Earnings Call. [Operator Instructions] Please note this event is being recorded.
Analyst Visit Confirms Growth Potential for Boston Scientific Corporation (BSX), Buy Rating Retained
Boston Scientific Corporation (NYSE:BSX) ranks among the best medical device stocks to invest in.
12 Best Medical Device Stocks to Invest In Now
As chronic diseases like diabetes and cancer become more common, medical device technology is becoming increasingly innovative.
What Makes Boston Scientific Corporation (BSX) an Investment Choice?
Polen Capital, an investment management company, released its “Polen Focus Growth Strategy” third-quarter 2025 investor letter. A copy of the letter can be downloaded here.
RBC Capital Maintains a Buy on Boston Scientific Corporation (BSX) With a $125 PT
Boston Scientific Corporation (NYSE:BSX) is one of the best medical stocks to buy now.
12 Best Medical Stocks to Buy Now
On September 26, Geoff Meacham, Managing Director of Citi Research, appeared on CNBC’s “Closing Bell Overtime” to talk about President Trump’s plan to impose a 100% tariff on “all any branded...
Hedge Fund Resource Center Billionaire Hedge Funds
